Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shorter treatment of catheter-related urinary tract infections
NL-OMON46655Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial in catheter-associated urinary tract infection (CAUTI) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Recurrence of symptomatic urinary tract infection during 90 days after end of treatment. Started Jul 2018; status: active, not recruiting.
02
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on NL-OMON46655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46655.